| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/30/2007 | EP1373220B1 Benzimidazoles that are useful in treating sexual dysfunction |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP1117667B1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS |
| 05/30/2007 | CN1972945A Selective antagonists of A2A adenosine receptors |
| 05/30/2007 | CN1972944A Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 05/30/2007 | CN1972943A New derivatives of 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxamide or 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxylic acid |
| 05/30/2007 | CN1972941A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists |
| 05/30/2007 | CN1972940A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
| 05/30/2007 | CN1972938A 环状胺化合物 Cyclic amine compound |
| 05/30/2007 | CN1972929A Heterocyclic CGRP antagonists for the treatment of migraine |
| 05/30/2007 | CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
| 05/30/2007 | CN1972911A 2-(1h-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 05/30/2007 | CN1972910A 内酰胺速激肽受体拮抗剂 Lactam tachykinin receptor antagonists |
| 05/30/2007 | CN1972903A 新的mao－b抑制剂 New mao-b inhibitor |
| 05/30/2007 | CN1972697A Compounds and methods for treating seizure disorders |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1970778A 碳水化合物 Carbohydrates |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1970074A Application of beta-protein inhibitor in preparation of medicament for treating genetic correlated disease |
| 05/30/2007 | CN1970002A Method for preparing minipill of 'Xue Fu Zhu Yu' |
| 05/30/2007 | CN1969989A Capsule for unblocking collaterals to treat arthritis |
| 05/30/2007 | CN1969986A Ganoderma lucidum capsule for improving sleep and immunity, preparation method and use thereof |
| 05/30/2007 | CN1969985A Method for preparing alcohol-decomposing powder |
| 05/30/2007 | CN1969972A Chinese medicinal powder for treating rheumatic disease |
| 05/30/2007 | CN1969918A 口服脂肪乳剂 Oral fat emulsions |
| 05/30/2007 | CN1969882A Sugar-free vitamin oral liquid |
| 05/30/2007 | CN1969861A Sustained release system of clozapine solid liposome microparticle |
| 05/30/2007 | CN1969859A Norepinephrine reuptake inhibitors and methods of using the same |
| 05/30/2007 | CN1969836A Ferulic acid and sodium ferulate preparation for inducing stem cell differentiating into nerve stem cell and pharmaceutical application thereof |
| 05/30/2007 | CN1969829A Clozapine encapsulated solid lipid microparticle and preparation process thereof |
| 05/30/2007 | CN1969814A Nasal administered preparation of melatonin |
| 05/30/2007 | CN1969691A Alcohol-decomposing beverage |
| 05/30/2007 | CN1969641A Sugar-free soybean milk for infants |
| 05/30/2007 | CN1969640A Liquid milk capable of supplying ketone when decomposed |
| 05/30/2007 | CN1318575C Protein conformational disease cell model and its use |
| 05/30/2007 | CN1318448C Recombined full length human brain red element, preparation method and application thereof |
| 05/30/2007 | CN1318435C Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318416C Indazole amide compounds as 5-serotoninergic agents |
| 05/30/2007 | CN1318414C Compound containing structure of o-naphthaquinone and application |
| 05/30/2007 | CN1318404C Aryl ureas as kinase inhibitors |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318087C Removing albumin nerve growth factor agent |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/30/2007 | CN1318045C Novel pharmaceutical composition and medical uses thereof |
| 05/30/2007 | CN1318027C GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 05/30/2007 | CN1318026C Solid pharmaceutical formulations comprising modafinil |
| 05/30/2007 | CN1318020C Blood nourishing, brain refreshing orally disintegrating tablet and its preparation process |
| 05/30/2007 | CN1317979C Modified methionine rich food products and process for their manufacture |
| 05/29/2007 | WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 05/29/2007 | USRE39667 3,3-Diphenylpropylamines, their use and preparation |
| 05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223778 5-substituted-2-arylpyridines |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223774 Benzamide 2-hydroxy-3-diaminoalkanes |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223767 Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists |
| 05/29/2007 | US7223765 3-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)propan-1-one or salts for example; psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder; high affinity for dopamine D4 receptors |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223755 Such as (2S,5S)-5-benzyl-6-hydroxy-2-(2-methylpropyl)-3-morpholinone, which has calpain inhibitory activity; for treating cataract or retinal ischemic disorder |
| 05/29/2007 | US7223753 Diazabicyclic biaryl derivatives |
| 05/29/2007 | US7223750 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders |
| 05/29/2007 | US7223593 Anticancer agents; gene coding immunomoderator cytokine protein |
| 05/29/2007 | US7223591 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/29/2007 | US7223425 Anti-depression pharmaceutical composition containing polygala extract |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | CA2214565C New cryptophycins from synthesis |
| 05/29/2007 | CA2197673C Drugs to improve synaptic transmission |
| 05/29/2007 | CA2090612C Method of reversing local anesthesia and reagent system therefor |
| 05/24/2007 | WO2007059219A1 Azaindazoles useful as inhibitors of kinases |
| 05/24/2007 | WO2007059039A1 Thyroxine derivatives for preconditioning against stroke |
| 05/24/2007 | WO2007058927A1 Histone deacetylase inhibitors as therapeutics for neurological diseases |
| 05/24/2007 | WO2007058902A1 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin |
| 05/24/2007 | WO2007058805A2 Compositions and methods for treating cns disorders |
| 05/24/2007 | WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 05/24/2007 | WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia |
| 05/24/2007 | WO2007058593A1 Quetiapine in a controlled release formulation |
| 05/24/2007 | WO2007058583A2 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | WO2007058582A1 Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |
| 05/24/2007 | WO2007058581A1 Novel 2-aminopyrimidine derivatives and their use |
| 05/24/2007 | WO2007058580A1 Novel 2-aminopyrimidinone derivatives and their use |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058305A1 Process for production of cinnamamide derivative |
| 05/24/2007 | WO2007058304A1 Salts of cynnamide compound or solvates thereof |
| 05/24/2007 | WO2007057775A1 Spiropiperidine derivatives |